RE, L., & DP, K. (2026). Does the Evidence Support High-Dose Liposomal Amphotericin B in the Treatment of Mucormycosis? The Journal of infectious diseases, 234(3), 331. https://doi.org/10.1093/infdis/jiag336
Παραπομπή σε μορφή Chicago (17η εκδ.)RE, Lewis, και Kontoyiannis DP. "Does the Evidence Support High-Dose Liposomal Amphotericin B in the Treatment of Mucormycosis?" The Journal of Infectious Diseases 234, no. 3 (2026): 331. https://doi.org/10.1093/infdis/jiag336.
Παραπομπή σε μορφή MLA (9th εκδ.)RE, Lewis, και Kontoyiannis DP. "Does the Evidence Support High-Dose Liposomal Amphotericin B in the Treatment of Mucormycosis?" The Journal of Infectious Diseases, vol. 234, no. 3, 2026, p. 331, https://doi.org/10.1093/infdis/jiag336.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.